Prominent Genotyping Assay Market Trend for 2025: CE-IVD Marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit For Treatment-Resistant Strains Of HIV-1

Which drivers are expected to have the greatest impact on the over the genotyping assay market's growth?
The genotyping assay market is expected to experience significant growth due to the increasing incidence of genetic disorders. Genetic disorders, which are medical conditions caused by abnormalities or mutations within a person's DNA, are prevalent. Genotyping assays are used to compare the DNA of affected individuals with that of healthy ones to identify any changes, revealing specific genetic mutations or variations associated with a particular genetic disorder. As an example, the UK-based registered charity, Gene People, reported in June 2023 that one in every 25 children in the UK suffers from a genetic disorder. This affects approximately 30,000 newborns and young children in the country and impacts more than 2.4 million children and adults annually. Hence, the escalating prevalence of genetic disorders is contributing to the growth of the genotyping assay market. The demand for personalized medicine is another driver for the growth of the genotyping assay market. Personalized medicine, which customizes medical treatment based on an individual's unique genetic composition, offers more accurate and effective healthcare interventions. Genotype assays play a crucial role in personalized medicine by analyzing an individual's genetic makeup, enabling the customization of medical treatments, drug selection, and dosages. For example, in January 2023, the Food and Drug Administration, a US-based federal agency, reported that the Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. 34% of these 35 therapeutic NMEs, which amounts to 12, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the surging demand for personalized medicine is boosting the growth of the genotyping assay market.

Get Your Genotyping Assay Market Report Here:
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

What is the future CAGR of the genotyping assay market, and how will it impact industry expansion?
In recent times, the market size of the genotyping assay has seen significant expansion. The expected growth will see it rise from $33.98 billion in 2024 to $41.6 billion in 2025 with a compound annual growth rate (CAGR) of 22.4%. This growth during the historic period is attributable to factors such as the use of traditional glassware, cultural and lifestyle impacts, economic conditions, the expansion of the hospitality and foodservice industry, and trends in gifting and decor.

The market for genotyping assays is projected to witness a steep rise in its value over the coming years, reaching $95.5 billion by 2029, with a compound annual growth rate (CAGR) of 23.1%. Factors such as customization, personal wellness, the rise of e-commerce, intelligent and functional glassware, along with culinary and mixology fashions contribute to its growth in the forecast period. The period also expects to see trends like material advancement, innovative shapes and designs, intelligent glassware, beverage specific glassware, and features focusing on health and safety.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp

How are the latest trends influencing the growth of the genotyping assay market?
Leading firms in the genotyping assay market are driving innovation in genomic research with developments like the CE-IVD marked assay, which is used for identifying resistant forms of HIV-1. The CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit is a Sanger sequencing-based assay specifically designed to analyse positive HIV samples for genetic variants that may display resistance to standard antiretroviral treatments. In January 2023, for example, US-based Thermo Fisher Scientific introduced the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. Equipped with unique features, this system identifies treatment-resistant HIV-1 strains by evaluating genomic changes, making use of HIV RNA, recognising drug resistance mutations through gold-standard Sanger sequencing technology, and is intended for clinical application. The introduction of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has contributed to advancements in identifying treatment-resistant HIV-1 strains. It provides easy-to-use reagents and controls, fulfills regulatory stipulations, delivers high-performance features, and is readily compatible with existing sequencing platforms and processes.

Which key market segments comprise the genotyping assay market and drive its revenue growth?
The genotyping assay market covered in this report is segmented -

1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics
2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies
3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes

Subsegments:
1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Genotyping Services, Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services
2) By Instruments: PCR Machines, Sequencing Instruments, Microarrays
3) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13444

What regions are at the forefront of genotyping assay market expansion?
North America was the largest region in the genotyping assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the genotyping assay market?
Major companies operating in the genotyping assay market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies PLC, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp

What Is Covered In The Genotyping Assay Global Market Report?

• Market Size Forecast: Examine the genotyping assay market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the genotyping assay market for a structured understanding.
• Key Players Overview: Analyze major players in the genotyping assay market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the genotyping assay market.
• Segment Contributions: Evaluate how different segments drive overall growth in the genotyping assay market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the genotyping assay market.
• Industry Challenges: Identify potential risks and obstacles affecting the genotyping assay market.
• Competitive Landscape: Review strategic developments in the genotyping assay market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.